HEADER HYDROLASE 28-APR-99 1QB1 TITLE BOVINE TRYPSIN WITH 1-[2-[5-[AMINO(IMINO)METHYL]-2-HYDROXYPHENOXY]-6- TITLE 2 [3-(4,5-DIHYDRO-1-METHYL-1H-IMIDAZOL-2-YL)PHENOXY]PYRIDIN-4- TITLE 3 YL]PIPERIDINE-3-CARBOXYLIC ACID (ZK-806974) COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEIN (TRYPSIN); COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: BOVINE TRYPSIN; COMPND 5 EC: 3.4.21.4 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: BOS TAURUS; SOURCE 3 ORGANISM_COMMON: CATTLE; SOURCE 4 ORGANISM_TAXID: 9913; SOURCE 5 ORGAN: PANCREAS; SOURCE 6 OTHER_DETAILS: BOEHRINGER MANNHEIM CATALOG NUMBER 109,827 KEYWDS HYDROLASE, SERINE PROTEINASE, PROTEIN-INHIBITOR COMPLEX, S1 POCKET, KEYWDS 2 FACTOR XA EXPDTA X-RAY DIFFRACTION AUTHOR M.WHITLOW REVDAT 4 24-JAN-18 1QB1 1 JRNL REVDAT 3 24-FEB-09 1QB1 1 VERSN REVDAT 2 01-APR-03 1QB1 1 JRNL REVDAT 1 29-APR-00 1QB1 0 JRNL AUTH M.WHITLOW,D.O.ARNAIZ,B.O.BUCKMAN,D.D.DAVEY,B.GRIEDEL, JRNL AUTH 2 W.J.GUILFORD,S.K.KOOVAKKAT,A.LIANG,R.MOHAN,G.B.PHILLIPS, JRNL AUTH 3 M.SETO,K.J.SHAW,W.XU,Z.ZHAO,D.R.LIGHT,M.M.MORRISSEY JRNL TITL CRYSTALLOGRAPHIC ANALYSIS OF POTENT AND SELECTIVE FACTOR XA JRNL TITL 2 INHIBITORS COMPLEXED TO BOVINE TRYPSIN. JRNL REF ACTA CRYSTALLOGR.,SECT.D V. 55 1395 1999 JRNL REFN ISSN 0907-4449 JRNL PMID 10417407 JRNL DOI 10.1107/S0907444999007350 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH W.BODE,R.HUBER REMARK 1 TITL CRYSTAL STRUCTURE ANALYSIS AND REFINEMENT OF TWO VARIANTS OF REMARK 1 TITL 2 TRIGONAL TRYPSINOGEN REMARK 1 REF FEBS LETT. V. 90 265 1978 REMARK 1 REFN ISSN 0014-5793 REMARK 1 DOI 10.1016/0014-5793(78)80382-2 REMARK 1 REFERENCE 2 REMARK 1 AUTH G.PHILLIPS,D.DAVEY,K.EAGEN,H.P.NG,M.PINKERTON,S.K.KOOVAKKAT, REMARK 1 AUTH 2 M.WHITLOW,A.LIANG,L.TRINH,M.M.MORRISSEY REMARK 1 TITL DESIGN, SYNTHESIS, AND ACTIVITY OF REMARK 1 TITL 2 2,6-DIPHENOXYPYRIDINE-DERIVED FACTOR XA INHIBITORS REMARK 1 REF J.MED.CHEM. V. 42 1749 1999 REMARK 1 REFN ISSN 0022-2623 REMARK 1 DOI 10.1021/JM980667K REMARK 1 REFERENCE 3 REMARK 1 AUTH G.B.PHILLIPS,B.O.BUCKMAN,D.D.DAVEY,K.A.EAGEN,W.J.GUILFORD, REMARK 1 AUTH 2 J.HINCHMAN,E.HO,S.KOOVAKKAT,A.LIANG,D.R.LIGHT,R.MOHAN, REMARK 1 AUTH 3 H.P.NG,J.POST,D.SMITH,B.SUBRAMANYAM,M.E.SULLIVAN,L.TRINH, REMARK 1 AUTH 4 R.VERGONA,J.WALTERS,K.WHITE,M.WHITLOW,S.WU,W.XU, REMARK 1 AUTH 5 M.M.MORRISSEY REMARK 1 TITL DISCOVERY OF REMARK 1 TITL 2 N-[2-[5-[AMINO(IMINO)METHYL]-2-HYDROXYPHENOXY]-3,5- REMARK 1 TITL 3 DIFLUORO-6-[3-(4,5-DIHYDRO-1-METHYL-1H-IMIDAZOL-2-YL) REMARK 1 TITL 4 PHENOXY] PYRIDIN-4-YL-N-METHYLGLYCINE (ZK-807834): A POTENT, REMARK 1 TITL 5 SELECTIVE AND ORALLY ACTIVE INHIBITOR OF THE BLOOD REMARK 1 TITL 6 COAGULATION ENZYME FACTOR XA REMARK 1 REF J.MED.CHEM. V. 41 3557 1998 REMARK 1 REFN ISSN 0022-2623 REMARK 1 DOI 10.1021/JM980280H REMARK 1 REFERENCE 4 REMARK 1 AUTH M.T.STUBBS,R.HUBER,W.BODE REMARK 1 TITL CRYSTAL STRUCTURES OF FACTOR XA SPECIFIC INHIBITORS IN REMARK 1 TITL 2 COMPLEX WITH TRYPSIN: STRUCTURAL GROUNDS FOR INHIBITION OF REMARK 1 TITL 3 FACTOR XA AND SELECTIVITY AGAINST THROMBIN REMARK 1 REF FEBS LETT. V. 375 103 1995 REMARK 1 REFN ISSN 0014-5793 REMARK 1 DOI 10.1016/0014-5793(95)01190-P REMARK 1 REFERENCE 5 REMARK 1 AUTH H.BRANDSTETTER,A.KUHNE,W.BODE,R.HUBER,W.VON DER SAAL, REMARK 1 AUTH 2 K.WIRTHENSOHN,R.A.ENGH REMARK 1 TITL X-RAY STRUCTURE OF ACTIVE SITE-INHIBITED CLOTTING FACTOR XA. REMARK 1 TITL 2 IMPLICATIONS FOR DRUG DESIGN AND SUBSTRATE RECOGNITION REMARK 1 REF J.BIOL.CHEM. V. 271 29988 1996 REMARK 1 REFN ISSN 0021-9258 REMARK 1 DOI 10.1074/JBC.271.47.29988 REMARK 1 REFERENCE 6 REMARK 1 AUTH K.PADMANABHAN,K.P.PADMANABHAN,A.TULINSKY,C.H.PARK,W.BODE, REMARK 1 AUTH 2 R.HUBER,D.T.BLANKENSHIP,A.D.CARDIN,W.KISIEL REMARK 1 TITL STRUCTURE OF HUMAN DES(1-45) FACTOR XA AT 2.2 A RESOLUTION REMARK 1 REF J.MOL.BIOL. V. 232 947 1993 REMARK 1 REFN ISSN 0022-2836 REMARK 1 DOI 10.1006/JMBI.1993.1441 REMARK 1 REFERENCE 7 REMARK 1 AUTH W.BODE,D.TURK,J.STURZEBECHER REMARK 1 TITL GEOMETRY OF BINDING OF THE BENZAMIDINE-AND ARGININE-BASED REMARK 1 TITL 2 INHIBITORS N REMARK 1 TITL 3 ALPHA-(2-NAPHTHYL-SULPHONYL-GLYCYL) REMARK 1 TITL 4 -DL-P-AMIDINOPHENYLALANYL-PIPERIDINE (NAPAP) AND REMARK 1 TITL 5 (2R,4R)-4-METHYL-1-[N REMARK 1 TITL 6 ALPHA-(3-METHYL-1,2,3,4-TETRAHYDRO-8-QUINOLINESULPHONYL)- REMARK 1 TITL 7 L-ARGINYL]-2-PIPERIDINE TO CARBOXYLIC ACID (MQPA) HUMAN REMARK 1 TITL 8 ALPHA-THROMBIN. X-RAY CRYSTALLOGRAPHIC DETERMINATION OF THE REMARK 1 TITL 9 NAPAP-TRYPSIN COMPLEX AND MODELING OF NAPAP-THROMBIN AND REMARK 1 TITL10 MQPA-THROMBIN REMARK 1 REF EUR.J.BIOCHEM. V. 193 175 1990 REMARK 1 REFN ISSN 0014-2956 REMARK 1 REFERENCE 8 REMARK 1 AUTH H.D.BARTUNIK,L.J.SUMMERS,H.H.BARTSCH REMARK 1 TITL CRYSTAL STRUCTURE OF BOVINE BETA-TRYPSIN AT 1.5 A RESOLUTION REMARK 1 TITL 2 IN A CRYSTAL FORM WITH LOW MOLECULAR PACKING DENSITY. ACTIVE REMARK 1 TITL 3 SITE GEOMETRY, ION PAIRS AND SOLVENT STRUCTURE REMARK 1 REF J.MOL.BIOL. V. 210 813 1989 REMARK 1 REFN ISSN 0022-2836 REMARK 2 REMARK 2 RESOLUTION. 1.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PROFFT REMARK 3 AUTHORS : KONNERT,HENDRICKSON,FINZEL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 10.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 3 NUMBER OF REFLECTIONS : 21586 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING + TEST SET) : NULL REMARK 3 R VALUE (WORKING SET) : 0.183 REMARK 3 FREE R VALUE : 0.237 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.000 REMARK 3 FREE R VALUE TEST SET COUNT : 890 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.1830 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.237 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 4.000 REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 980 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 22476 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1629 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 42 REMARK 3 SOLVENT ATOMS : 218 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 DISTANCE RESTRAINTS. RMS SIGMA REMARK 3 BOND LENGTH (A) : 0.016 ; 0.020 REMARK 3 ANGLE DISTANCE (A) : 0.030 ; 0.030 REMARK 3 INTRAPLANAR 1-4 DISTANCE (A) : 0.044 ; 0.050 REMARK 3 H-BOND OR METAL COORDINATION (A) : NULL ; NULL REMARK 3 REMARK 3 PLANE RESTRAINT (A) : 0.015 ; 0.020 REMARK 3 CHIRAL-CENTER RESTRAINT (A**3) : 0.165 ; 0.150 REMARK 3 REMARK 3 NON-BONDED CONTACT RESTRAINTS. REMARK 3 SINGLE TORSION (A) : 0.167 ; 0.500 REMARK 3 MULTIPLE TORSION (A) : 0.214 ; 0.500 REMARK 3 H-BOND (X...Y) (A) : 0.228 ; 0.500 REMARK 3 H-BOND (X-H...Y) (A) : NULL ; 0.500 REMARK 3 REMARK 3 CONFORMATIONAL TORSION ANGLE RESTRAINTS. REMARK 3 SPECIFIED (DEGREES) : NULL ; 15.000 REMARK 3 PLANAR (DEGREES) : 3.000 ; 3.000 REMARK 3 STAGGERED (DEGREES) : 16.200; 15.000 REMARK 3 TRANSVERSE (DEGREES) : 21.300; 20.000 REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.628 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.429 ; 3.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 3.135 ; 3.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 4.552 ; 4.000 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1QB1 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 04-MAY-99. REMARK 100 THE DEPOSITION ID IS D_1000009057. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 12-APR-95 REMARK 200 TEMPERATURE (KELVIN) : 297 REMARK 200 PH : 7.4 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : SIEMENS REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 26263 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.800 REMARK 200 RESOLUTION RANGE LOW (A) : 10.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 200 DATA REDUNDANCY : 3.400 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.07800 REMARK 200 FOR THE DATA SET : 16.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.90 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : 3.11 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.22200 REMARK 200 FOR SHELL : 3.110 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: DIRECT REPLACEMENT REMARK 200 SOFTWARE USED: PROFFT REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: STARTING FROM THE TRYPSIN 2-AMINOBENZIMIDAZOLE STRUCTURE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 58.40 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.00 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: MICROCRYSTALS WERE INITIALLY GROWN REMARK 280 USING THE HANGING DROP METHOD IN LINBRO CULTURE PLATES. REMARK 280 REFERENCES 7 (BODE, TURK & STURZEBACHER) AND 8 (BARTUNIK, REMARK 280 SUMMERS & BARTSH) HAVE DESCRIBED THE CRYSTALLIZATION OF THE REMARK 280 ORTHORHOMBIC FORM OF BOVINE TRYPSIN. CRYSTALS WERE SEEDING INTO REMARK 280 DROPS CONTAINING 40 MG/ML BOVINE TRYPSIN, 0.0125 M BENZAMIDINE, REMARK 280 0.7 TO 0.9 M AS, 0.05 M MES PH 6.0, 0.0025 M CACL2 AFTER REMARK 280 EQUILIBRATION AGAINST THE CRYSTALLIZATION RESERVOIR FOR 1 DAY. REMARK 280 THE CRYSTALLIZATION RESERVOIRS CONTAINED 1.4 TO 1.8 M AS, 0.1 M REMARK 280 MES PH 6.0, 0.005 M CACL2., PH 7.4, VAPOR DIFFUSION, HANGING REMARK 280 DROP, TEMPERATURE 297K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 31.58000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 34.67500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 31.89000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 34.67500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 31.58000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 31.89000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE BIOLOGICAL ASSEMBLY IS A MONOMER. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 GLU A 173 CD GLU A 173 OE2 0.090 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP A 151 CB - CG - OD2 ANGL. DEV. = -7.3 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 59 -80.93 -127.48 REMARK 500 ASN A 67 -12.97 85.27 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA A 301 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 VAL A 63 O REMARK 620 2 GLU A 68 OE2 86.5 REMARK 620 3 GLU A 58 OE1 164.7 104.1 REMARK 620 4 ASN A 60 O 85.8 156.8 88.2 REMARK 620 5 HOH A 323 O 110.3 77.8 83.1 84.4 REMARK 620 6 HOH A 340 O 85.6 93.6 82.8 107.6 161.1 REMARK 620 N 1 2 3 4 5 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CA A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 974 A 300 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1QBN RELATED DB: PDB REMARK 900 FACTOR XA INHIBITOR ZK-806688 IN BOVINE TRYPSIN REMARK 900 RELATED ID: 1MTW RELATED DB: PDB REMARK 900 FACTOR XA INHIBITOR DX-9065A IN BOVINE TRYPSIN REMARK 900 RELATED ID: 1QBO RELATED DB: PDB REMARK 900 FACTOR XA INHIBITOR ZK-806711 IN BOVINE TRYPSIN REMARK 900 RELATED ID: 1MTU RELATED DB: PDB REMARK 900 FACTOR XA INHIBITOR ZK-805633 IN BOVINE TRYPSIN - STARTING MODEL REMARK 900 RELATED ID: 1FAX RELATED DB: PDB REMARK 900 FACTOR XA INHIBITOR DX-9065A IN HUMAN FACTOR XA DBREF 1QB1 A 7 229 UNP P00760 TRY1_BOVIN 1 223 SEQRES 1 A 223 ILE VAL GLY GLY TYR THR CYS GLY ALA ASN THR VAL PRO SEQRES 2 A 223 TYR GLN VAL SER LEU ASN SER GLY TYR HIS PHE CYS GLY SEQRES 3 A 223 GLY SER LEU ILE ASN SER GLN TRP VAL VAL SER ALA ALA SEQRES 4 A 223 HIS CYS TYR LYS SER GLY ILE GLN VAL ARG LEU GLY GLU SEQRES 5 A 223 ASP ASN ILE ASN VAL VAL GLU GLY ASN GLU GLN PHE ILE SEQRES 6 A 223 SER ALA SER LYS SER ILE VAL HIS PRO SER TYR ASN SER SEQRES 7 A 223 ASN THR LEU ASN ASN ASP ILE MET LEU ILE LYS LEU LYS SEQRES 8 A 223 SER ALA ALA SER LEU ASN SER ARG VAL ALA SER ILE SER SEQRES 9 A 223 LEU PRO THR SER CYS ALA SER ALA GLY THR GLN CYS LEU SEQRES 10 A 223 ILE SER GLY TRP GLY ASN THR LYS SER SER GLY THR SER SEQRES 11 A 223 TYR PRO ASP VAL LEU LYS CYS LEU LYS ALA PRO ILE LEU SEQRES 12 A 223 SER ASP SER SER CYS LYS SER ALA TYR PRO GLY GLN ILE SEQRES 13 A 223 THR SER ASN MET PHE CYS ALA GLY TYR LEU GLU GLY GLY SEQRES 14 A 223 LYS ASP SER CYS GLN GLY ASP SER GLY GLY PRO VAL VAL SEQRES 15 A 223 CYS SER GLY LYS LEU GLN GLY ILE VAL SER TRP GLY SER SEQRES 16 A 223 GLY CYS ALA GLN LYS ASN LYS PRO GLY VAL TYR THR LYS SEQRES 17 A 223 VAL CYS ASN TYR VAL SER TRP ILE LYS GLN THR ILE ALA SEQRES 18 A 223 SER ASN HET CA A 301 1 HET 974 A 300 41 HETNAM CA CALCIUM ION HETNAM 974 1-[2-[5-[AMINO(IMINO)METHYL]-2-HYDROXYPHENOXY]-6-[3-(4, HETNAM 2 974 5-DIHYDRO-1-METHYL-1H-IMIDAZOL-2-YL)PHENOXY] PYRIDIN- HETNAM 3 974 4-YL]PIPERIDINE-3-CARBOXYLIC ACID HETSYN 974 ZK-806974 FORMUL 2 CA CA 2+ FORMUL 3 974 C28 H27 F2 N6 O5 1+ FORMUL 4 HOH *218(H2 O) HELIX 1 1 ALA A 44 TYR A 48 5 5 HELIX 2 2 SER A 150 TYR A 158 1 9 HELIX 3 3 TYR A 218 SER A 228 1 11 SHEET 1 A 7 TYR A 11 THR A 12 0 SHEET 2 A 7 LYS A 142 PRO A 147 -1 N CYS A 143 O TYR A 11 SHEET 3 A 7 GLN A 121 GLY A 126 -1 O CYS A 122 N ALA A 146 SHEET 4 A 7 PRO A 186 CYS A 189 -1 O PRO A 186 N SER A 125 SHEET 5 A 7 LYS A 192 TRP A 199 -1 O LYS A 192 N CYS A 189 SHEET 6 A 7 GLY A 210 LYS A 214 -1 N VAL A 211 O TRP A 199 SHEET 7 A 7 MET A 166 ALA A 169 -1 O PHE A 167 N TYR A 212 SHEET 1 B 7 GLN A 21 ASN A 25 0 SHEET 2 B 7 HIS A 29 LEU A 35 -1 N PHE A 30 O LEU A 24 SHEET 3 B 7 GLN A 21 ASN A 25 -1 N VAL A 22 O GLY A 33 SHEET 4 B 7 GLN A 53 LEU A 56 -1 O GLN A 53 N ASN A 25 SHEET 5 B 7 GLN A 69 VAL A 78 -1 O GLN A 69 N LEU A 56 SHEET 6 B 7 MET A 92 LEU A 96 -1 O LEU A 93 N ILE A 77 SHEET 7 B 7 TRP A 40 SER A 43 -1 O VAL A 41 N ILE A 94 SSBOND 1 CYS A 13 CYS A 143 1555 1555 2.05 SSBOND 2 CYS A 31 CYS A 47 1555 1555 2.03 SSBOND 3 CYS A 115 CYS A 216 1555 1555 2.09 SSBOND 4 CYS A 122 CYS A 189 1555 1555 1.97 SSBOND 5 CYS A 154 CYS A 168 1555 1555 2.03 SSBOND 6 CYS A 179 CYS A 203 1555 1555 2.10 LINK CA CA A 301 O VAL A 63 1555 1555 2.24 LINK CA CA A 301 OE2 GLU A 68 1555 1555 2.41 LINK CA CA A 301 OE1 GLU A 58 1555 1555 2.31 LINK CA CA A 301 O ASN A 60 1555 1555 2.24 LINK CA CA A 301 O HOH A 323 1555 1555 2.45 LINK CA CA A 301 O HOH A 340 1555 1555 2.45 SITE 1 AC1 6 GLU A 58 ASN A 60 VAL A 63 GLU A 68 SITE 2 AC1 6 HOH A 323 HOH A 340 SITE 1 AC2 12 SER A 84 ASN A 85 THR A 86 GLN A 161 SITE 2 AC2 12 ASP A 177 SER A 178 GLN A 180 SER A 183 SITE 3 AC2 12 TRP A 199 GLY A 200 GLY A 202 GLY A 210 CRYST1 63.160 63.780 69.350 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015833 0.000000 0.000000 0.00000 SCALE2 0.000000 0.015679 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014420 0.00000